Thursday, December 19, 2013
Publication and contact
Factor Xa; thrombin
(factor IIa; F2)
In vitro and rat studies identified a dual factor Xa and
thrombin inhibitor that could help treat thrombosis. In vitro, the
blocked both factor Xa and thrombin with low nanomolar potency. In a rat
model of venous thrombosis, i.v. and oral dosing of SAR107375 had
antithrombotic activity. In a rat model of arterial thrombosis, oral dosing
of SAR107375 decreased bleeding compared with oral dosing of the factor Xa
or the thrombin inhibitor Pradaxa
and had comparable antithrombotic activity. Next steps include further
assessing advantages of SAR107375 such as reduced bleeding risks relative to
Ingelheim GmbH markets the thrombin inhibitor Pradaxa to
AG and Johnson
& Johnson market Xarelto to treat deep vein thrombosis
(DVT), fibrillation, pulmonary embolism (PE), stroke and VTE.
Published online Dec. 19, 2013
Patent application filed
covering inhibitor; licensed to an undisclosed Chinese company
Meneyrol, J. et al. J.
Med. Chem.; published online Oct. 31, 2013;
Contact: Gilbert Lassalle, Sanofi R&D, Toulouse, France
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]